Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

被引：0
|
作者：
Awada, G. [1 ]
Ozdemir, I. [2 ]
Schwarze, J. K. [1 ]
Daeninck, E. [1 ]
Gondry, O. [2 ]
Jansen, Y. [3 ]
Seremet, T. [1 ]
Keyaerts, M. [2 ]
Everaert, H. [2 ]
Neyns, B. [1 ]
机构：
[1] Univ Ziekenhuis Brussel, Med Oncol, Brussels, Belgium
[2] Univ Ziekenhuis Brussel, Nucl Med, Brussels, Belgium
[3] Univ Ziekenhuis Brussel, Surg Oncol, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy
    Tricarico, Pierre
    Chardin, David
    Martin, Nicolas
    Contu, Sara
    Hugonnet, Florent
    Otto, Josiane
    Humbert, Olivier
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [32] Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT in Patients with Follicular Lymphoma
    Liang, Jin-Hua
    Zhang, Yun-Ping
    Xia, Jun
    Ding, Chong-Yang
    Wu, Wei
    Wang, Li
    Cao, Lei
    Zhu, Hua-Yuan
    Fan, Lei
    Li, Tian-Nv
    Li, Jian-Yong
    Xu, Wei
    CANCER RESEARCH AND TREATMENT, 2019, 51 (04): : 1479 - 1487
  • [33] Proteomic comparison based on 18FDG-PET/CT defined metabolic tumor volume in non-metastatic nasopharyngeal carcinoma
    Chen, C.
    Li, L.
    Fei, Z.
    Wang, J.
    Chen, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [34] 18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma
    Hindso, Tine Gadegaard
    Martinussen, Torben
    Bjerrum, Camilla Wium
    Keller, Sune Hogild
    Loft, Annika
    Sjol, Mette Bagger
    Nissen, Kristoffer
    Faber, Carsten
    Donia, Marco
    Svane, Inge Marie
    Ellebaek, Eva
    Heegaard, Steffen
    Kiilgaard, Jens Folke
    Madsen, Karine
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [35] Methodological Aspects and the Prognostic Value of Metabolic Tumor Volume assessed with 18F-FDG PET/CT in Lymphomas
    Tutino, Francesca
    Giovannini, Elisabetta
    Pastorino, Sara
    Ferrando, Ornella
    Giovacchini, Giampiero
    Ciarmiello, Andrea
    CURRENT RADIOPHARMACEUTICALS, 2022, 15 (04) : 259 - 270
  • [36] The role of 18FDG-PET/CT target volume delineation in locally advanced cervical cancer radiotherapy
    Vicenzi, L.
    Costantini, S.
    Di Carlo, C.
    Cucciarelli, F.
    Mariucci, C.
    Palucci, A.
    Burroni, L.
    Valenti, M.
    Mantello, G.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S342 - S343
  • [37] Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments
    Jemaa, S.
    Paulson, J. N.
    Hutchings, M.
    Kostakoglu, L.
    Trotman, J.
    Tracy, S.
    de Crespigny, A.
    Carano, R. A. D.
    El-Galaly, T. C.
    Nielsen, T. G.
    Bengtsson, T.
    CANCER IMAGING, 2022, 22 (01)
  • [38] Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments
    S. Jemaa
    J. N. Paulson
    M. Hutchings
    L. Kostakoglu
    J. Trotman
    S. Tracy
    A. de Crespigny
    R. A. D. Carano
    T. C. El-Galaly
    T. G. Nielsen
    T. Bengtsson
    Cancer Imaging, 22
  • [39] F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer
    Gallicchio, Rosj
    Nardelli, Anna
    Venetucci, Angela
    Capacchione, Daniela
    Pelagalli, Alessandra
    Sirignano, Cesare
    Mainenti, Pierpaolo
    Pedicini, Piernicola
    Guglielmi, Giuseppe
    Storto, Giovanni
    EUROPEAN JOURNAL OF RADIOLOGY, 2017, 93 : 107 - 113
  • [40] [18F] FDG PET predicts outcome in NPC treated patients
    Lee, Jong-Kang
    Chang, Chih-Yung
    Liu, Wen-Shan
    Liu, Rung-Tong
    Huang, Wen-Sheng
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
12345